Breaking News, Promotions & Moves

Qosina Names David Oh to Represent Korean Market

David brings more than two decades of experience to his new role.

By: Kristin Brooks

Managing Editor, Contract Pharma

Qosina, a global supplier of OEM single-use components to the medical and pharmaceutical industries, has named David Oh as the new representative for the Korean market.
 
David brings more than two decades of experience to his new role, having been actively involved in the medical device industry since graduating from Penn State University in 2000. With a solid foundation in market analysis and sales forecasting, he has a proven track record of driving business growth and implementing effective sales strategies. Additionally, David has a keen eye for monitoring service quality, guaranteeing that Qosina’s customers in Korea receive nothing short of excellence in all their interactions.
 
David also bring expertise in navigating regulatory matters, particularly with the Ministry of Food and Drug Safety (MFDS). His experience in developing policies to handle regulatory affairs will help the Qosina customer move towards compliance with standards and regulations. David is also well-versed in developing quality control strategies essential for maintaining MFDS approvals and advising customers on the requirements set forth by the Korea Medical Device Industry Association (KMDIA).
 
“We are thrilled to welcome David Oh to the Qosina family,” said Jeff Cushner, Vice President of Sales at Qosina. “His extensive experience and expertise make him an invaluable asset to our team as we continue to expand our presence in the Korean market. We are confident that David will provide unparalleled support and solutions in Korea.”

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters